These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 10749128)

  • 1. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
    Rudland PS; Platt-Higgins A; Renshaw C; West CR; Winstanley JH; Robertson L; Barraclough R
    Cancer Res; 2000 Mar; 60(6):1595-603. PubMed ID: 10749128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer.
    Platt-Higgins AM; Renshaw CA; West CR; Winstanley JH; De Silva Rudland S; Barraclough R; Rudland PS
    Int J Cancer; 2000 Mar; 89(2):198-208. PubMed ID: 10754500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
    Rudland PS; Platt-Higgins A; El-Tanani M; De Silva Rudland S; Barraclough R; Winstanley JH; Howitt R; West CR
    Cancer Res; 2002 Jun; 62(12):3417-27. PubMed ID: 12067984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer.
    de Silva Rudland S; Martin L; Roshanlall C; Winstanley J; Leinster S; Platt-Higgins A; Carroll J; West C; Barraclough R; Rudland P
    Clin Cancer Res; 2006 Feb; 12(4):1192-200. PubMed ID: 16489073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
    Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
    Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.
    Gaci Z; Bouin-Pineau MH; Gaci M; Daban A; Ingrand P; Métayé T
    Int J Oncol; 2001 Apr; 18(4):793-800. PubMed ID: 11251176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients.
    Wang G; Platt-Higgins A; Carroll J; de Silva Rudland S; Winstanley J; Barraclough R; Rudland PS
    Cancer Res; 2006 Jan; 66(2):1199-207. PubMed ID: 16424059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
    Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
    Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
    Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
    Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
    Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi OP
    J Clin Oncol; 1993 Jan; 11(1):36-43. PubMed ID: 8093367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.
    Egeland EV; Boye K; Park D; Synnestvedt M; Sauer T; ; Naume B; Borgen E; Mælandsmo GM
    Breast Cancer Res Treat; 2017 Feb; 162(1):127-137. PubMed ID: 28058579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis-associated protein S100A4--a potential prognostic marker for colorectal cancer.
    Hemandas AK; Salto-Tellez M; Maricar SH; Leong AF; Leow CK
    J Surg Oncol; 2006 May; 93(6):498-503. PubMed ID: 16615153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma--a multivariate analysis of prognostic factors.
    Kim JP; Oh ST; Hwang TS; Chi JG
    J Korean Med Sci; 1994 Jun; 9(3):248-53. PubMed ID: 7993593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of S100A4 expression in gallbladder cancer.
    Nakamura T; Ajiki T; Murao S; Kamigaki T; Maeda S; Ku Y; Kuroda Y
    Int J Oncol; 2002 May; 20(5):937-41. PubMed ID: 11956586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies.
    Pedersen KB; Nesland JM; Fodstad Ø; Maelandsmo GM
    Br J Cancer; 2002 Nov; 87(11):1281-6. PubMed ID: 12439718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins.
    Zhang GJ; Tsuda H; Adachi I; Fukutomi T; Yamamoto H; Hirohashi S
    Jpn J Clin Oncol; 1997 Dec; 27(6):371-7. PubMed ID: 9437997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.